First COVID-19 vaccine trial in South Africa begin

Loading player...
VOW FM 88.1 — The first clinical trial for for a vaccine against Covid-19 will star this week. This was announce on 23 June 2020, during a virtual press conference hosted by the University of the Witwatersrand, Johannesburg. The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes Covid-19.In South Africa, at least 80,000 people have already been diagnosed with Covid-19 and more than 1,674 have died from Covid-19 since March, when the President declared a state of disaster and national lockdown.

SPEAKERS at the announcement included Professor Johnny Mahlangu, Head of the School of Pathology, Faculty of Health
Sciences, Wits University
​​​
Professor Shabir Madhi, Principal Investigator and Director: South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (VIDA) at Wits University, and the National Research Foundation/Department of Science and Technology SARChI Chair in Vaccine Preventable Diseases
​​​
​​​Professor Helen Rees, Chair of the African Regional Immunization Technical Advisory Group of the World Health Organization, Chair of the Programme and Policy Committee of Gavi, the Vaccine Alliance, Chair of the South African Health Products Regulatory Authority, and Executive Director of the Wits Reproductive Health and HIV Institute (Wits RHI)

Professor Glenda Gray, President and Chief Executive Officer, South African Medical Research Council, and Full Research Professor in the School of Clinical Medicine, Wits University

Professor Jeffrey Mphahlele, Vice President: Research, South African Medical Research Council

Dr Sandile Buthelezi, Director-General: National Department of Health
23 Jun 2020 English South Africa Technology · Music

Other recent episodes

IN CONVERSATION WITH Dr Phiyani Lebea ON SCIENCE WISE

Dr Phiyani Lebea, a South African biotechnology researcher, entrepreneur, and animal health specialist whose work focuses on developing innovative solutions to some of Africa's most pressing livestock disease challenges. He is the Chief Scientific Officer of TokaBio, a biotechnology company dedicated to advancing diagnostics, vaccine development, and disease surveillance technologies…
16 Jun 46 min

IN CONVERSATION WITH Dr Kristie Bloom ON SCIENCE WISE

Dr Kristie Bloom is a scientist at the Wits/SAMRC Antiviral Gene Therapy Research Unit at the University of the Witwatersrand. Her research focuses on nextgeneration vaccine technologies, particularly mRNA-based vaccines for tuberculosis. She works on understanding how specialised immune responses, especially tissue-resident memory T-cells in the lungs, can improve protection…
9 Jun 28 min

IN CONVERSATION WITH Professor Laura Pereira ON SCIENCE WISE

Professor Laura Pereira is a South African sustainability scientist whose work focuses on climate change, biodiversity, food systems, resilience, and the future of sustainable development. She is a professor at the Global Change Institute at the University of the Witwatersrand and a researcher at the Stockholm Resilience Centre at Stockholm…
26 May 35 min

IN CONVERSATION WITH Mr Light Mkhumbuza ON SCIENCE WISE

Light Mkhumbuza is a PhD student at the University of Graz whose research focuses on combining integrated photonics with microfluidics, essentially bringing optical circuits and fluid channels to better understand how light interacts with liquids and particles at very small scales. Before this, Light completed his MSc research at the…
19 May 31 min

IN CONVERSATION WITH HLENGIWE MTSHALI ON SCIENCE WISE

Hlengiwe Mtshali is a Red List Scientist at the South African National Biodiversity Institute, where she works within the Threatened Species Programme. Her work focuses on assessing the risk of extinction for South Africa’s plant species using internationally recognised IUCN Red List standards, helping guide national conservation priorities and biodiversity…
5 May 30 min